nonprofit logo

Dana-Farber Cancer Institute Inc

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 042263040 ✦ Boston, MA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Dana-Farber Cancer Institute Inc?

Dana-Farber Cancer Institute Inc, based on the provided information, is a dedicated nonprofit organization focused on delivering specialized, caring cancer treatment to both children and adults. Committed to making strides in the field, they also actively advance research to broaden the knowledge of various cancer types and related diseases, with the ultimate goal of finding cures and preventing their occurrence. The organization is deeply rooted in providing expert care, marked by compassion and dedication to support individuals during their cancer journey.


Official website here: www.dana-farber.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 100%, Four-Star out of Four Star Rating

The Dana-Farber Cancer Institute has achieved a commendable Four-Star rating from Charity Navigator, indicating a high level of accountability and financial health. The organization scores exceptionally well in various metrics, including a robust 89.75% of its expenses allocated directly to programs. With a majority of independent board members and transparent financial practices, Dana-Farber demonstrates strong governance and effective oversight.

User feedback, however, presents a mixed picture. While many reviews highlight the exceptional quality of cancer care provided by their medical staff, several clients have expressed frustration with the administrative side of the organization. Complaints regarding rude interactions, difficulty in communication, and the overall stress caused by the administrative process have been prevalent among those seeking treatment.

Additionally, there are concerns regarding the compensation of top executives, with some former clients and members of the public expressing dissatisfaction with the high salaries of leadership. This has led to criticism about the organization’s priorities, suggesting that funds may not be directed sufficiently towards research and patient care. Overall, while Dana-Farber is recognized for its impactful cancer treatment, the feedback underscores significant areas for improvement in patient support services and public trust.


This AI summary has been generated from information found on Charity Navigator and Great Nonprofits.

Is Dana-Farber Cancer Institute Inc legitimate?

Dana-Farber Cancer Institute Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Dana-Farber Cancer Institute Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $11,054,329
Professional Fundraising Fees: $3,929,270
Other Salaries and Wages: $636,395,164

For more financial information, click here


Official website here: www.dana-farber.org

What is the mission statement of Dana-Farber Cancer Institute Inc?

Dana-Farber Cancer Institute is dedicated to delivering specialized care to children and adults diagnosed with cancer. Their mission extends beyond providing compassionate care, as they also strive to expand the knowledge and find cures for various types of cancer and related diseases. By combining their expertise and commitment, Dana-Farber Cancer Institute aims to make advancements in cancer treatment, understanding, and prevention. Their ultimate goal is to create a world where cancer no longer poses a threat.


Official website here: www.dana-farber.org

Who is the CEO of Dana-Farber Cancer Institute Inc?

Unavailable The CEO's salary of Dana-Farber Cancer Institute Inc is $513,026 and their total compensation is $564,467.


Official website here: www.dana-farber.org

What is the revenue of Dana-Farber Cancer Institute Inc?

Dana-Farber Cancer Institute Inc's revenue in 2022 was $2,669,084,593.


Official website here: www.dana-farber.org

Who are the executives of Dana-Farber Cancer Institute Inc and what are their salaries?

The average compensation at Dana-Farber Cancer Institute Inc during 2022 was $80,951. There are 7998 employees and 500 volunteers at Dana-Farber Cancer Institute Inc.


Here are 94 key members and their salaries (Dana-Farber Cancer Institute Inc's CEO's salary is $513,026 and their total compensation is $564,467):


John J O'Connor (Trustee Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Joshua Bekenstein (Trustee Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Laurie H Glimcher Md (Trustee, President, And Ceo)
  • Compensation: $3,672,655
  • Related: $0
  • Other: $321,403
Monica Chandra (Trustee Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Richard Lubin (Trustee Vice-Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Afsaneh Beschloss (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Alison Jaffe (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Amy Berylson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Amy Kyle Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Andrew Janower (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Andrew Kaplan (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Beth Terrana (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Betty Ann Blum (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Bradley Lucas (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Brian Knez (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Christopher Hadley (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Demond Martin (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Doug Grip (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Eric Miller (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Eric Schlager (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Esta Stecher (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Fatima Penrose (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Frederica Williams (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Harvey Berger Md (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Hise Gibson (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
James Mccann (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jane Brock-Wilson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jane Jamieson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jennifer Perini (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jessica Knez (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Jill Greenthal (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jodi Walker (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jose Aguerrevere (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Joseph Norberg (Trustee (End 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Karen Daley Phd Mph Rn Fann (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Karen Linde Packman (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kate Gulliver (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Kevin Dasilva (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kimberly Sherman Stamler (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Laura Sen (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Lisa Ferraro (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Lori Whelan (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Louise Svanberg (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mary Ann Tocio (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Meg Reynolds (Trustee (As Of 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael Eisenson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael Trotsky (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Moria Forbes (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Nancy Gibson (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Nancy Lotane (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paul Marcus (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Peter Palandjian (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Phillip Gross (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert Reynolds (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert Sachs (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert Stansky (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Roger Berkowitz (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Roger Medel (Trustee (End 1/31/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Ronald Sullivan (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sandra Stratford Md (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Stephen Fine (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Stephen Koster Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Steven Koppel (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Susan Alexander Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Susan Poduska (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sushil Tuli (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Theodore Pasquarello (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Timothy Cohen (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Tracey Mccain Esq (Trustee)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jennifer Willcox Esq (Asst. Sec. Gc (Begin 6/1/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
John O Chesley Esq (Asst. Sec. Gc (Begin 1/14/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
John Ryan Esq (Asst. Sec. Gen. Cnsl. (End 1/14/22))
  • Compensation: $617,744
  • Related: $0
  • Other: $31,945
Michael L Reney (Cfo Assistant Treasurer)
  • Compensation: $835,469
  • Related: $0
  • Other: $37,481
William Hahn Md Phd (Coo Evp)
  • Compensation: $855,136
  • Related: $0
  • Other: $37,402
Barrett J Rollins Md Phd (Sr. Advisor President Ceo)
  • Compensation: $513,026
  • Related: $0
  • Other: $51,441
Benjamin Ebert Md Phd (Chair Of Medical Oncology)
  • Compensation: $199,529
  • Related: $0
  • Other: $8,869
Craig A Bunnell Md (Chief Medical Officer)
  • Compensation: $762,033
  • Related: $0
  • Other: $40,568
Jeffrey Meyerhardt Md Phd (Chief Clinical Research Officer)
  • Compensation: $488,567
  • Related: $0
  • Other: $70,862
Kevin Haigis (Chief Scientific Officer)
  • Compensation: $524,839
  • Related: $0
  • Other: $58,480
Maria Megdal (Svp Of Institue Operations)
  • Compensation: $518,918
  • Related: $0
  • Other: $52,529
Melany Duval (Svp Of Development)
  • Compensation: $725,483
  • Related: $0
  • Other: $51,770
Sylvia A Bartel Rph Mhp (Vp Of Pharmacy Services)
  • Compensation: $321,990
  • Related: $0
  • Other: $65,749
Wendy Gettleman (Vp Of Facilities Management Real Estate)
  • Compensation: $347,799
  • Related: $0
  • Other: $69,288
Edward J Benz Jr Md (President Ceo Emeritus)
  • Compensation: $2,163,654
  • Related: $0
  • Other: $51,485
Eric Winer Md (Chief Of Div. Of Women'S Cancers)
  • Compensation: $797,539
  • Related: $0
  • Other: $47,595
Matthew Meyerson Md (Professor)
  • Compensation: $903,547
  • Related: $0
  • Other: $69,876
Michael Constantine Md (Milford Medical Dir. - Hematol Onc.)
  • Compensation: $758,741
  • Related: $0
  • Other: $58,121
Robert Soiffer Md (Chief Of Hemotologic Malignancies)
  • Compensation: $712,796
  • Related: $0
  • Other: $54,177
Bruce Johnson Md (Senior Advisor To President Ceo)
  • Compensation: $671,141
  • Related: $0
  • Other: $56,584
Drew Memmott (Former Key Employee)
  • Compensation: $301,819
  • Related: $0
  • Other: $39,066
Elizabeth Liebow (Chief Integration Officer)
  • Compensation: $458,662
  • Related: $0
  • Other: $54,674
James D Griffin Md (Professor Of Medicine)
  • Compensation: $681,419
  • Related: $0
  • Other: $59,640
James Terwilliger (Former Officer)
  • Compensation: $360,500
  • Related: $0
  • Other: $0
Richard S Boskey Esq (Former Officer)
  • Compensation: $799,400
  • Related: $0
  • Other: $51,348


Official website here: www.dana-farber.org

Where can I find the form 990 for Dana-Farber Cancer Institute Inc?

Dana-Farber Cancer Institute Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.dana-farber.org

Learn more at the official website: www.dana-farber.org

Mission Statement of Dana-Farber Cancer Institute Inc

Dana-Farber Cancer Institute, a renowned institution, is dedicated to making a significant impact on the lives of children and adults diagnosed with cancer. With a deep-rooted commitment to delivering expert and compassionate care, the institute is not only focused on alleviating the physical symptoms but also on providing emotional support throughout the entire treatment process.

Beyond its clinical efforts, Dana-Farber Cancer Institute is an unequivocal leader in the scientific community, relentlessly pursuing advancements in the understanding, treatment, cure, and prevention of cancer and related diseases. The institute's unwavering mission is to transform the landscape of cancer care and ultimately, save lives.

By bringing together world-renowned researchers, clinicians, and scientists, Dana-Farber Cancer Institute fosters a collaborative and interdisciplinary environment where bold discoveries are made and translated into innovative therapies. The ultimate goal is to improve patient outcomes and pave the way for a cancer-free future.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Dana-Farber Cancer Institute Inc has a profound impact on the field of oncology and the lives of patients battling cancer. By providing expert, compassionate care, it serves both children and adults, addressing their medical and emotional needs during challenging times. The institute is dedicated to advancing the understanding and treatment of cancer through cutting-edge research, which not only aims to develop new therapies but also to improve existing treatment protocols.

Located in Boston, Massachusetts, Dana-Farber is at the forefront of cancer research, contributing significantly to the discovery of innovative and effective treatment options. Its focus on the prevention and cure of cancer positions it as a leader in efforts to combat various forms of this disease. The integration of research with patient care ensures that advancements in science directly benefit those receiving treatment, enhancing their chances of recovery. Overall, Dana-Farber's contributions are integral to improving patient outcomes and advancing the fight against cancer on multiple fronts.




This information is meant to be a general summary of Dana-Farber Cancer Institute Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$2,669,084,593 (2022)
Expenses
$2,558,704,532 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $928,841
  • Program Service Revenue: $1,911,183,785
  • Gross Receipts: $2,672,062,824

Assets and Liabilities:

  • Total Assets: $4,291,020,227
  • Total Liabilities: $1,487,687,279
  • Net Assets: $2,803,332,948

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

NET PATIENT SERVICE REVENUE

Revenue

$1,896,457,895

NETWORK COLLABORATION

Revenue

$12,022,552

LINAC

Revenue

$2,703,338

Organization Details

Founding Year

1951

Main Address

450 BROOKLINE AVENUE BP418, BOSTON, MA, 02215

NTEE Category

Code: H300 - Medical research

If you are a representative of Dana-Farber Cancer Institute Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.